Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization

Abstract The authors performed a retrospective and comparative study to compare the efficacy of intravitreal aflibercept and bevacizumab for patients with myopic choroidal neovascularization (mCNV). The patients with treatment-naïve mCNV received 1 + PRN intravitreal bevacizumab from March 2008 to F...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jia-Kang Wang, Tzu-Lun Huang, Pei-Yao Chang, Yen-Ting Chen, Chin-Wei Chang, Fang-Ting Chen, Yung-Ray Hsu, Yun-Ju Chen
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2018-09-01
coleção:	Scientific Reports
Assuntos:	Intravitreal Aflibercept Choroidal Neovascularization Best-corrected Visual Acuity (BCVA) Mean BCVA Aflibercept Group
Acesso em linha:	https://doi.org/10.1038/s41598-018-32761-z
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!